Russell Investments Group
NXTM

Russell Investments Group’s NxStage Medical Inc. NXTM Stock Holding History

Russell Investments Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-110,661
Closed -$3.17M – 3103
2018
Q4 		$3.17M Sell
110,661
-16,483
-13% -$468K 0.01% 1360
2018
Q3 		$3.55M Hold
127,144
– – 0.01% 1463
2018
Q2 		$3.55M Sell
127,144
-131,364
-51% -$3.52M 0.01% 1447
2018
Q1 		$6.43M Buy
258,508
+55,402
+27% +$1.35M 0.01% 1212
2017
Q4 		$5M Buy
203,106
+198,570
+4,378% +$5.23M 0.01% 1348
2017
Q3 		$125K Sell
4,536
-14,181
-76% -$378K ﹤0.01% 2744
2017
Q2 		$469K Sell
18,717
-10,130
-35% -$251K ﹤0.01% 2439
2017
Q1 		$773K Buy
28,847
+11,668
+68% +$322K ﹤0.01% 2237
2016
Q4 		$449K Buy
+17,179
New +$425K ﹤0.01% 2502

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Russell Investments Group's NXTM Position: Q1 2019 in Review

Russell Investments Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 110,661 shares — an estimated $3.17M sold.

Russell Investments Group first reported a position in NXTM in Q4 2016 and held it in 9 quarters. The position peaked at $6.43M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Russell Investments Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Russell Investments Group sold 110,661 NxStage Medical Inc. shares in Q1 2019, an estimated $3.17M.
  • Russell Investments Group first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 9 quarters.
  • Russell Investments Group's NxStage Medical Inc. position peaked at $6.43M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Russell Investments Group's 13F filing for Q1 2019, filed 13 May 2019.